Skip to main content
OpenTrials
Completed

NCT Number: NCT00888537

Wiser Choices in Acute Myocardial Infarction

Patients who are hospitalized because of a heart attack are prescribed a number of medicines to help the heart heal. The investigators will examine different ways in which clinicians share information about those treatment options with patients and the impact that this can have on patients' choices and health.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Acute Myocardial Infarction Cardiovascular Diseases Heart Diseases Infarction Ischemia Myocardial Infarction Myocardial Ischemia Necrosis Pathologic Processes Pathological Conditions, Signs and Symptoms Vascular Diseases

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Saint Marys Hospital, Mayo Clinic

Rochester, Minnesota, 55905, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Between the ages of 18 and 90
  • Hospitalized at Saint Marys Hospital
  • A primary diagnosis of AMI,
  • Have heart rate, blood pressure, troponin and creatinine measurements,
  • There is an intention to offer treatment medications
  • Are able and willing to provide informed consent

Exclusion criteria

  • Have not had a myocardial infarction
  • Have significant cognitive, visual impairment,
  • Non-English speaker
  • Have a Do Not Intubate/Do Not Resuscitate (DNI/DNR) status
  • Will be discharged to a nursing home
  • AMI is not the presumptive diagnosis

Treatment and study plan

AMI Choice Decision Aid

Other

The decision aid describes the risk of dying in the first six months following a heart attack without and with taking a bundle of medications to help the heart heal.

Usual Care

Other

Patients and clinicians in this arm will discuss medications to help the heart heal after a heart attack in their usual manner.

Primary outcomes

  1. Increases adherence to cardiac medications with proven benefits

    Time frame: 6 months

  2. Reduces patients' decisional conflict (increase patient decisional quality)

    Time frame: During hospital stay

  3. Decreases rehospitalization rates and death

    Time frame: 5 weeks and 6 months

  4. Increase patient knowledge of medication to help the heart heal

    Time frame: During hospital stay

Sponsors and collaborators

Lead sponsor

Mayo Clinic

Other

Registry information

Important dates

Study start
2009
Primary completion
2011
Study completion
2011
First posted
Apr 27, 2009
Registry last updated
Mar 21, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.